Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Daiichi Sankyo
Johnson and Johnson
Cantor Fitzgerald
Harvard Business School
QuintilesIMS
Baxter
Moodys
Cerilliant
Federal Trade Commission
US Army

Generated: February 19, 2018

DrugPatentWatch Database Preview

Xspire Company Profile

« Back to Dashboard

What is the competitive landscape for XSPIRE, and what generic and branded alternatives to XSPIRE drugs are available?

XSPIRE has three approved drugs.



Summary for Xspire
US Patents:0
Tradenames:3
Ingredients:2
NDAs:3

Drugs and US Patents for Xspire

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-004 Jul 21, 2009 RX Yes No ➤ Sign Up ➤ Sign Up
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-003 Approved Prior to Jan 1, 1982 RX Yes Yes ➤ Sign Up ➤ Sign Up
Xspire Pharma DEXAMETHASONE dexamethasone TABLET;ORAL 088237-001 Apr 28, 1983 BP RX No No ➤ Sign Up ➤ Sign Up
Xspire Pharma FENOPROFEN CALCIUM fenoprofen calcium TABLET;ORAL 072267-001 Aug 17, 1988 RX No Yes ➤ Sign Up ➤ Sign Up
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-002 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for Xspire

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-003 Approved Prior to Jan 1, 1982 3,600,437 ➤ Sign Up
Xspire Pharma NALFON fenoprofen calcium CAPSULE;ORAL 017604-002 Approved Prior to Jan 1, 1982 3,600,437 ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Cerilliant
Merck
Chinese Patent Office
Citi
Deloitte
Moodys
UBS
Fuji

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot